knowledge -WSS

knowledge

author：explore 2025-10-02 11:09:29 - browse：6525

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Pharma patents targeted by Biden in move to slash drug prices

explore

WSS

FDA early review: GLP

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

At JPM 2024, hospital systems pitch financial strength to investors

Medicare Advantage overpayments discussion gets experts fired up

focus

knowledge

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA early review: GLP

At least 13 dead in Texas as scorching temps continue

In shift, Texas to cover initial consult for Afghan baby's gene therapy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

At least 13 dead in Texas as scorching temps continue

FDA needs staff influx to meet gene therapy needs, Marks says

Continuity nursing helped my family in our darkest PICU moments

After sickle

hotspot

The woman behind the Dana Farber

Nonprofit, backed by Microsoft, to certify AI tools in health care

Spinal cord stimulation reduces pain in amputees, study finds

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Male doctors called my cancer incurable. A female doctor showed it wasn't

focus

hotspot

explore

focus